Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.

In COVID-19, Latest News
by ClinOwl May 23, 2021

Passive immunization with polyclonal hyper immunoglobulin (HIG) therapy represents a proven strategy by transferring immunoglobulins to patients to confer immediate protection against a range of pathogens including infectious agents and […]

Read More

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Factors ID’d for Strong Antibody Response in COVID-19

COVID-19 Pandemic Challenges Osteoporosis Management

AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

Survival From COVID-19 High in Patients With Psoriasis

FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.